Microplastics – A Growing Concern as Carcinogens in Cancer Etiology: Emphasis on Biochemical and Molecular Mechanisms
Naveen Kumar,
No information about this author
Mridul Lamba,
No information about this author
Ashok Kumar Pachar
No information about this author
et al.
Cell Biochemistry and Biophysics,
Journal Year:
2024,
Volume and Issue:
82(4), P. 3109 - 3121
Published: July 20, 2024
Language: Английский
Pharmacological Insights: Mitochondrial ROS Generation by FNC (Azvudine) in Dalton’s Lymphoma Cells Revealed by Super Resolution Imaging
Naveen Kumar,
No information about this author
Vikram Delu,
No information about this author
Ilya V. Ulasov
No information about this author
et al.
Cell Biochemistry and Biophysics,
Journal Year:
2024,
Volume and Issue:
82(2), P. 873 - 883
Published: March 14, 2024
Language: Английский
Fluorescent tetrazolylpyrene unnatural nucleoside in sensing BSA protein
Journal of Photochemistry and Photobiology A Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 116290 - 116290
Published: Jan. 1, 2025
Oxadiazole-2-thione based Co(II) Complexes as Antiproliferative Agents: Synthesis and Structural Characterization
Ajay K. Vishwakarma,
No information about this author
Alok Shukla,
No information about this author
Sankatha P Sonkar
No information about this author
et al.
Journal of Molecular Structure,
Journal Year:
2025,
Volume and Issue:
unknown, P. 141781 - 141781
Published: Feb. 1, 2025
Language: Английский
An electrochemical detection method for polyvinyl chloride microplastics in water bodies
Journal of Molecular Structure,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142086 - 142086
Published: March 1, 2025
Language: Английский
Potent cytotoxicity and induction of ROS-mediated genomic instability, mitochondrial dysfunction, and apoptosis by Y2O3 NPs in Hep-G2 hepatic cancer cells
Hanan R. H. Mohamed,
No information about this author
Rawan Essam,
No information about this author
Basma A. Mohamed
No information about this author
et al.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 10, 2025
Abstract
Hepatic
cancer,
one
of
the
most
prevalent
and
lethal
cancers
globally,
remains
a
significant
health
challenge,
with
limited
treatment
options
underscoring
urgent
need
for
novel,
more
effective
therapies.
Yttrium
oxide
nanoparticles
(Y
2
O
3
NPs)
have
attracted
attention
in
nanomedicine
due
to
their
promising
properties,
including
enhanced
drug
delivery,
imaging
capabilities,
therapeutic
effects.
However,
specific
impact
Y
NPs
on
hepatic
cancer
is
largely
unexplored.
Therefore,
this
study
was
conducted
assess
cytotoxic
effects
cell
viability,
reactive
oxygen
species
(ROS)
generation,
genomic
stability,
mitochondrial
integrity,
apoptosis
induction
Hep-G2
cells.
The
results
from
SRB
cytotoxicity
assay
demonstrated
strong
concentration-dependent
decrease
notably
low
half-maximal
inhibitory
concentration
(IC50)
value
13.15
µg/ml.
Exposure
IC50
led
increased
ROS
DNA
damage
induction,
loss
membrane
potential.
Furthermore,
expression
pro-apoptotic
p53
ND3
genes
significantly
upregulated,
while
anti-apoptotic
Bcl-2
gene
markedly
downregulated,
triggering
cells
after
72
h
exposure
NPs.
Collectively,
these
findings
highlight
potential
emphasizing
further
research
fully
explore
efficacy
as
option
liver
cancer.
Language: Английский
Antitumor potential of ivermectin against T-cell lymphoma-bearing hosts
Medical Oncology,
Journal Year:
2025,
Volume and Issue:
42(5)
Published: April 21, 2025
Language: Английский
Unveiling the potency of ZnO and CuO nanocomposites in combating hepatocellular carcinoma by inducing cell death and suppressing migration
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: May 3, 2025
Abstract
Human
hepatocellular
carcinoma
(HCC)
is
recognized
as
one
of
the
leading
causes
death
globally
and
resistant
to
several
anticancer
drugs.
As
a
result,
it
critical
identify
more
effective
druggable
therapies.
Metal
oxide
nanoparticles
(MO-NPs),
especially
nanocomposites,
have
recently
received
much
attention
owing
their
potential
applications
in
cancer
therapy.
In
this
study,
we
synthesized
zinc
(ZnO)
copper
(CuO)
nanocomposites
different
ratios
(N1,
N2,
N3).
We
evaluated
cytotoxicity
against
two
HCC
cell
lines
(HepG2
HuH-7)
normal
liver
(BNL),
compared
with
Sorafenib
standard
Then,
investigated
underlying
mechanisms
action
employing
flow
cytometry,
migration
assay,
western
blot.
The
results
showed
that
nanocomposite
an
equal
ratio
both
ZnO
CuO-NPs
(N1)
exhibited
highest
cytotoxic
activity
on
HuH7
line
while
exerting
no
detrimental
impact
rat
epithelial
cells.
Further
investigation
into
toxicity
N1
revealed
three
modalities
induced
(apoptotic,
necrotic,
autophagic)
along
S-
G2/M
cycle
arrest,
suggesting
mitotic
catastrophe.
Furthermore,
displayed
potent
anti-migratory
activity,
surpassing
sorafenib,
upregulated
protein
level
autophagy
marker
beclin-1,
downregulated
EMT-marker
vimentin.
Overall,
our
findings
combining
ZnO-NPs
intriguing
combating
HCC,
providing
prospective
guidance
for
evolving
therapy
bimetallic
NPs.
Language: Английский